Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (1-10 of 458) with videos related to

Pageof 46
Sort By:
Current Opinion in Pediatrics|January 22, 2005
The biologic basis for neuroblastoma heterogeneity and risk stratificationJohn M Maris
Cancer Cell|December 30, 2008
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastomaJohn M Maris
Cancer Cell|January 18, 2020
When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid TumorsMark Yarmarkovich, John M Maris
Cancer Letters|June 2, 2005
Prospects for therapeutic inhibition of neuroblastoma angiogenesisSuzanne Shusterman, John M Maris
Magnetic Resonance Annual|January 1, 1986
Magnetic resonance spectroscopy of neoplasmsJ M Maris, B Chance
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Molecular biology of neuroblastomaJ M Maris, K K Matthay
Cancer Discovery|March 12, 2013
Targeting MYCN: a good BET for improving neuroblastoma therapy?Robert W Schnepp, John M Maris
Cancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M Maris
Cancer|November 6, 2015
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterationsKristopher R Bosse, John M Maris
Pageof 46

Showing results (1-10 of 458) with videos related to

Sort By:
Pageof 46
Current Opinion in Pediatrics|January 22, 2005
The biologic basis for neuroblastoma heterogeneity and risk stratificationJohn M Maris
Cancer Cell|December 30, 2008
Unholy matrimony: Aurora A and N-Myc as malignant partners in neuroblastomaJohn M Maris
Cancer Cell|January 18, 2020
When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid TumorsMark Yarmarkovich, John M Maris
Cancer Letters|June 2, 2005
Prospects for therapeutic inhibition of neuroblastoma angiogenesisSuzanne Shusterman, John M Maris
Magnetic Resonance Annual|January 1, 1986
Magnetic resonance spectroscopy of neoplasmsJ M Maris, B Chance
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Molecular biology of neuroblastomaJ M Maris, K K Matthay
Cancer Discovery|March 12, 2013
Targeting MYCN: a good BET for improving neuroblastoma therapy?Robert W Schnepp, John M Maris
Cancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M Maris
Cancer|November 6, 2015
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterationsKristopher R Bosse, John M Maris
Pageof 46